Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jun 21:16:154.
doi: 10.1186/s12891-015-0615-1.

α-Melanocyte-stimulating-hormone (α-MSH) modulates human chondrocyte activation induced by proinflammatory cytokines

Affiliations

α-Melanocyte-stimulating-hormone (α-MSH) modulates human chondrocyte activation induced by proinflammatory cytokines

Franco Capsoni et al. BMC Musculoskelet Disord. .

Abstract

Background: Alpha-melanocyte-stimulating-hormone (α-MSH) has marked anti-inflammatory potential. Proinflammatory cytokines are critical mediators of the disturbed cartilage homeostasis in osteoarthritis, inhibiting anabolic activities and increasing catabolic activities in chondrocytes. Since human chondrocytes express α-MSH receptors, we evaluated the role of the peptide in modulating chondrocyte production of pro-inflammatory cytokines, matrix metalloproteinases (MMPs), tissue inhibitors of MMPs (TIMPs), inducible nitric oxide synthase (iNOS) and nitric oxide (NO) in response to interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α).

Methods: Human articular chondrocytes were obtained from osteoarthritic joint cartilage from subjects undergoing hip routine arthroplasty procedures. The cells were cultured with or without α-MSH in the presence of IL-1β or TNF-α. Cell-free supernatants were collected and cells immediately lysed for RNA purification. Expression of cytokines, MMPs, TIMPs, iNOS was determined by Reverse Transcription Real-time Polymerase Chain Reaction and enzyme-linked immunosorbent assay. Griess reaction was used for NO quantification.

Results: Gene expression and secretion of IL-6, IL-8, MMP-3, MMP-13 were significantly increased in IL-1β or TNF-α-stimulated chondrocytes; α-MSH did not modify the release of IL-6 or IL-8 while the peptide significantly reduced their gene expression on TNF-α-stimulated cells. A significant inhibition of MMP3 gene expression and secretion from IL-1β or TNFα-stimulated chondrocytes was induced by α-MSH. On the other hand, α-MSH did not modify the release of MMP-13 by cytokine-stimulated chondrocyte but significantly decreased gene expression of the molecule on TNF-α-stimulated cells. Detectable amount of TIMP-3 and TIMP-4 were present in the supernatants of resting chondrocytes and a significant increase of TIMP-3 gene expression and release was induced by α-MSH on unstimulated cells. TIMP-3 secretion and gene expression were significantly increased in IL-1β-stimulated chondrocytes and α-MSH down-regulated gene expression but not secretion of the molecule. TIMP-4 gene expression (but not secretion) was moderately induced in IL-1β-stimulated chondrocytes with a down-regulation exerted by α-MSH. IL-1β and TNF-α were potent stimuli for NO production and iNOS gene expression by chondrocytes; no inhibition was induced by α-MSH on cytokine-stimulated NO production, while the peptide significantly reduced gene expression of iNOS.

Conclusions: Our results underscore a potential anti-inflammatory and chondroprotective activity exerted by α-MSH, increasing TIMP-3 gene expression and release on resting cells and down- modulating TNF-α-induced activation of human chondrocytes. However, the discrepancy between the influences exerted by α-MSH on gene expression and protein release as well as the difference in the inhibitory pattern exerted by α-MSH in TNF-α- or IL-1β-stimulated cells leave some uncertainty on the role of the peptide on chondrocyte modulation.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Effect of α-MSH on IL-6 and IL-8 secretion (a) and gene expression (b) in IL-1β-stimulated chondrocytes. Human primary chondrocytes were incubated for 4 h at 37 °C with 10−6M α-MSH and further cultured for 40 h in the presence or absence of 10 ng/mL IL-1β. IL-6 and IL-8 concentration in the supernatans (a) and gene expression (b) were then measured. Data from 4 separate experiments (± S.E.M.) are shown. *p < 0.0001 vs Medium
Fig. 2
Fig. 2
Effect of α-MSH on IL-6 and IL-8 secretion (a) and gene expression (b) in TNF-α-stimulated chondrocytes. Human primary chondrocytes were incubated for 4 h at 37 °C with 10−6M α-MSH and further cultured for 40 h in the presence or absence of 10 ng/mL TNF-α. IL-6 and IL-8 concentration in the supernatans (a) and gene expression (b) were then measured. Data from 4 separate experiments (± S.E.M.) are shown. *p < 0.0001 vs Medium; ° p < 0.05 vs TNF-α
Fig. 3
Fig. 3
Effect of α-MSH on MMP-3 secretion (a) and gene expression (b) in IL-1β or TNF-α-stimulated chondrocytes. Human primary chondrocytes were incubated for 4 h at 37 °C with 10−6M α-MSH and further cultured for 40 h in the presence or absence of 10 ng/mL IL-1β or TNF-α. MMP-3 concentration in the supernatans (a) and gene expression (b) were then measured. Data from 4 separate experiments (± S.E.M.) are shown. * p < 0.0001 vs Medium; § p < 0.001 vs IL-1β; ° p < 0.01 vs TNF-α; °° p < 0.001 vs TNF-α
Fig. 4
Fig. 4
Effect of α-MSH on MMP-13 secretion (a) and gene expression (b) in IL-1β or TNF-α-stimulated chondrocytes. Human primary chondrocytes were incubated for 4 h at 37 °C with 10−6M α-MSH and further cultured for 40 h in the presence or absence of 10 ng/mL IL-1β or TNF-α. MMP-13 concentration in the supernatans (a) and gene expression (b) were then measured. Data from 4 separate experiments (± S.E.M.) are shown. * p < 0.0001 vs Medium; °p < 0.05 vs TNF-α
Fig. 5
Fig. 5
Effect of α-MSH on TIMP-3 secretion (a) and gene expression (b) in IL-1β or TNF-α-stimulated chondrocytes. Human primary chondrocytes were incubated for 4 h at 37 °C with 10−6M α-MSH and further cultured for 40 h in the presence or absence of 10 ng/mL IL-1β or TNF-α. TIMP-3 concentration in the supernatans (a) and gene expression (b) were then measured. Data from 4 separate experiments (± S.E.M.) are shown. *P < 0.002 vs Medium; **p < 0.001 vs Medium; ° p < 0.02 vs Medium; °° p < 0.002 vs Medium; § p < 0.05 vs IL-1β
Fig. 6
Fig. 6
Effect of α-MSH on TIMP-4 secretion (a) and gene expression (b) in IL-1β or TNF-α-stimulated chondrocytes. Human primary chondrocytes were incubated for 4 h at 37 °C with 10−6M α-MSH and further cultured for 40 h in the presence or absence of 10 ng/mL IL-1β or TNF-α. TIMP-4 concentration in the supernatans (a) and gene expression (b) were then measured. Data from 4 separate experiments (± S.E.M.) are shown. *p < 0.02 vs Medium; ° P < 0.05 vs IL-1β
Fig. 7
Fig. 7
Effect of α-MSH on NO secretion and iNOS gene expression in IL-1β or TNF-α-stimulated chondrocytes. Human primary chondrocytes were incubated for 4 h at 37 °C with 10−6M α-MSH and further cultured for 40 h in the presence or absence of 10 ng/mL IL-1β or TNF-α. NO concentration in the supernatans (a) and iNOS gene expression (b) were then measured. Data from 4 separate experiments (± S.E.M.) are shown. *p < 0.0001 vs Medium; § p < 0.005 vs IL-1β; °p < 0.005 vs TNF-α

References

    1. Goldring MB. Update on the biology of the chondrocyte and new approaches to treating cartilage diseases. Best Pract Res Clin Rheumatol. 2006;20:1003–25. doi: 10.1016/j.berh.2006.06.003. - DOI - PubMed
    1. Aigner T, Sachse A, Gebhard PM, Roach HI. Osteoarthritis: Pathobiology-targets and ways for therapeutic intervention. Adv Drug Deliv Rev. 2006;58:128–49. doi: 10.1016/j.addr.2006.01.020. - DOI - PubMed
    1. Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2011;7:33–42. doi: 10.1038/nrrheum.2010.196. - DOI - PubMed
    1. Martel-Pelletier J, Wildi LM, Pelletier JP. Future therapeutics for osteoarthritis. Bone. 2012;51:297–311. doi: 10.1016/j.bone.2011.10.008. - DOI - PubMed
    1. Catania A. Neuroprotective actions of melanocortins: a therapeutic opportunity. Trends Neurosci. 2008;31:353–60. doi: 10.1016/j.tins.2008.04.002. - DOI - PubMed

Publication types

MeSH terms